1.

Development of a Novel Inhibitory Chimeric Anti-HER2 Monoclonal Antibody

دوره 16، شماره 1، خرداد 2019، صفحه 26-42
Mohammad Mehdi Amiri؛ Tannaz Bahadori؛ Tahereh Soltantoyeh؛ Reza Hosseini-Ghatar؛ Forough Golsaz-Shirazi؛ Mahmood Jeddi-Tehrani؛ Fazel Shokri

2.

Novel Monoclonal Antibodies Specific for Human Ki67 and P53 Tumor Markers in Breast Cancer Tissue Samples

دوره 20، شماره 2، شهریور 2023، صفحه 177-189
Masoud Hassanzadeh Makoui؛ Maryam Mobini؛ Jalal Khoshnoodi؛ Tannaz Bahadori؛ Forough Golsaz-Shirazi؛ Hedieh Moradi Tabriz؛ Zahra Madjd؛ Mahmood Jeddi-Tehrani؛ Amir-Hassan Zarnani؛ Mohammad Mehdi Amiri؛ Fazel Shokri

3.

Optimization of an Efficient Cell Culture Hepatitis B Infection System for Assessment of Hepatitis B Virus Neutralizing Monoclonal Antibodies

دوره 19، شماره 3، آذر 2022، صفحه 278-298
Hamzeh Sarvnaz؛ Sahar Asadi-Asadabad؛ Mohammad Mehdi Amiri؛ Mojgan Ghaedi؛ Ulrike Protzer؛ Mahmood Jeddi-Tehrani؛ Forough Golsaz-Shirazi؛ Fazel Shokri

4.

Overall status of Epstein-Barr virus infection, IFN-α, and TLR-7/9 in patients with Systemic Lupus Erythematosus

دوره 18، شماره 3، آذر 2021، صفحه 230-240
Sayed Mahdi Marashi؛ Shima Izadi؛ Seyed Reza Najafizadeh؛ Ahmad Nejati؛ Majid Teymoori-Rad؛ Shohreh Shahmahmoodi؛ Forough Golsaz-Shirazi؛ Fazel Shokri

5.

Polyclonal Antibody against Different Extracellular Subdomains of HER2 Induces Tumor Growth Inhibition in vitro

دوره 14، شماره 3، آذر 2017، صفحه 200-214
Reza Hosseini-Ghatar؛ Tahereh Soltantoyeh؛ Motahareh Bahadori؛ Jalal Khoshnoodi؛ Forough Golsaz-Shirazi؛ Mahmood Jeddi-Tehrani؛ Mohammad Mehdi Amiri؛ Fazel Shokri


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب